Skip to content
Research Article Open access CC BY 4.0

A Retrospective Review of Rifampicin-Resistant Mycobacterium tuberculosis between 2015 and 2017 in Port Harcourt, Nigeria

R. M. Nwalozie, O. E. Agbagwa, G. Mac-Fiberesima

International Journal of TROPICAL DISEASE & Health · pp. 1–6 · Published 22 Mar 2019

10.9734/ijtdh/2019/v35i230117

Abstract

Background: The diagnosis and treatment of drug resistant tuberculosis (TB) is a significant challenge for the control of TB in Nigeria. Aim: The study was carried out to assess the prevalence of rifampicin-resistant TB at the point of initial diagnosis among subjects suspected of TB. Methods: A retrospective review of Mycobacterium tuberculosis (MTB) and rifampicin resistance detected by GeneXpert™ analysis between 2015 and 2017 in Braithwaite Memorial Specialist Hospital was carried out. Results: A total of 6733 samples were received and analyzed in the period under review, 1252 (19%) were positive for Mycobacterium tuberculosis and 5841 (81%) were negative. The prevalence of Mycobacterium tuberculosis was 24.56%, 20.11% and 16.86% from 2015 to 2017 respectively. There was a significant decline in the prevalence of MTB from 2015 to 2017 (c2 = 33.59, p = 0.0001). Rifampicin (RIF) resistance was 5.42%, 5.86% and 6.22% respectively from 2015 to 2017; but the trend was not statistically significant (c2 = 0.21; p = 0.6418). Conclusion: The study showed that despite a decrease in the prevalence of tuberculosis infection there was an increase in rifampicin resistance from 5.42% to 6.22% between 2015 and 2017. There is an urgent need to improve the management of TB in the Port Harcourt metropolis to improve treatment outcomes and to prevent the proliferation of drug resistant strains.

Gene Xpert rifampicin-resistance trend tuberculosis

References (10)

  1. 1 The Growing Burden of Tuberculosis [DOI]
  2. 2 Rapid Molecular Detection of Tuberculosis and Rifampin Resistance [DOI]
  3. 3 Screening for HIV-Associated Tuberculosis and Rifampicin Resistance before Antiretroviral Therapy Using the Xpert MTB/RIF Assay: A Prospective Study [DOI]
  4. 4 Autopsy causes of death in HIV-positive individuals in sub-Saharan Africa and correlation with clinical diagnoses.
  5. 5 Tuberculosis among nomads in Adamawa, Nigeria: outcomes from two years of active case finding [DOI]
  6. 6 Validation of the GenoType® MTBDRplus assay for detection of MDR-TB in a public health laboratory in Thailand [DOI]
  7. 7 Testing Pooled Sputum with Xpert MTB/RIF for Diagnosis of Pulmonary Tuberculosis To Increase Affordability in Low-Income Countries [DOI]
  8. 8 Diagnostic accuracy of xpert test in tuberculosis detection: A systematic review and meta-analysis [DOI]
  9. 9 The hidden costs of installing xpert machines in a tuberculosis high-burden country: experiences from Nigeria [DOI]
  10. 10 Factors Associated with Tuberculosis and Rifampicin-Resistant Tuberculosis amongst Symptomatic Patients in India: A Retrospective Analysis [DOI]

Cited by 4

Detection of Mutations in Genes Associated with Multidrug Resistance in the Mycobacterium tuberculosis Complex among HIV/Tuberculosis Co-Infected Patients in N’Djamena, Chad

Abakar Oumar Mahamat, Abderrazzack Adoum Fouda, Richard Bongo Nare Ngandolo · Journal of Biosciences and Medicines · 2026

Showing 1 of 4 known citations — external sources report more than can currently be individually listed.

Related research

Article metrics

Real usage data collected on this platform.

50

Page views

0

PDF downloads

12

Outbound clicks

4

Citations

Views over time

Views by country

Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".

Traffic sources

Referring site, by host.

Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.